S. Kahlert

727 total citations
12 papers, 539 citations indexed

About

S. Kahlert is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, S. Kahlert has authored 12 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in S. Kahlert's work include Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and HER2/EGFR in Cancer Research (5 papers). S. Kahlert is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and HER2/EGFR in Cancer Research (5 papers). S. Kahlert collaborates with scholars based in Germany and Switzerland. S. Kahlert's co-authors include Michael Untch, Volker Heinemann, Nadia Harbeck, Gottfried E. Konecny, Bernhard Heinrich, Hans‐Joachim Stemmler, Annette Lebeau, R. Kreienberg, Andreas du Bois and Gϋnter von Minckwitz and has published in prestigious journals such as Journal of Clinical Oncology, The Breast and International Journal of Surgery.

In The Last Decade

S. Kahlert

11 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Kahlert Germany 6 445 299 138 132 93 12 539
Angela Sciandivasci Italy 11 425 1.0× 286 1.0× 191 1.4× 85 0.6× 63 0.7× 23 593
Maik Hauschild Germany 11 402 0.9× 415 1.4× 111 0.8× 94 0.7× 161 1.7× 24 593
Hannah Douthwaite Spain 6 717 1.6× 428 1.4× 190 1.4× 262 2.0× 78 0.8× 8 835
M. Byakhov Spain 4 376 0.8× 240 0.8× 66 0.5× 136 1.0× 44 0.5× 6 451
Maggie Wilcox United Kingdom 6 340 0.8× 304 1.0× 168 1.2× 42 0.3× 83 0.9× 9 512
Jean-François Boileau Canada 4 722 1.6× 440 1.5× 182 1.3× 322 2.4× 91 1.0× 5 856
Maeve Waldron-Lynch United States 10 427 1.0× 248 0.8× 228 1.7× 95 0.7× 52 0.6× 21 564
Christopher Stokoe United States 9 480 1.1× 254 0.8× 134 1.0× 189 1.4× 22 0.2× 17 547
Tse-Kuan Yu United States 9 229 0.5× 208 0.7× 96 0.7× 55 0.4× 60 0.6× 9 382
G. Raab Germany 7 487 1.1× 483 1.6× 81 0.6× 67 0.5× 178 1.9× 19 650

Countries citing papers authored by S. Kahlert

Since Specialization
Citations

This map shows the geographic impact of S. Kahlert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kahlert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kahlert more than expected).

Fields of papers citing papers by S. Kahlert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Kahlert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kahlert. The network helps show where S. Kahlert may publish in the future.

Co-authorship network of co-authors of S. Kahlert

This figure shows the co-authorship network connecting the top 25 collaborators of S. Kahlert. A scholar is included among the top collaborators of S. Kahlert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Kahlert. S. Kahlert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kolben, T, Theresa Schwarz, Cornelia Blume, et al.. (2015). Surgical management of ipsilateral breast tumor recurrence. International Journal of Surgery. 23(Pt A). 141–146. 17 indexed citations
3.
Stieber, P, et al.. (2008). The Reality in the Surveillance of Breast Cancer Survivors—Results of a Patient Survey. Breast Cancer Basic and Clinical Research. 1. BCBCR.S511–BCBCR.S511. 6 indexed citations
4.
Stieber, P, et al.. (2007). Kinetics of CEA and CA15–3 correlate with response in patients undergoing chemotherapy for metastatic breast cancer. Journal of Clinical Oncology. 25(18_suppl). 1087–1087. 1 indexed citations
5.
Ditsch, Nina, S. Kahlert, M Lenhard, et al.. (2006). Immunologische Therapie beim Mammakarzinom. Der Onkologe. 12(9). 945–954.
6.
Stemmler, Hans‐Joachim, et al.. (2005). Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. The Breast. 15(2). 219–225. 120 indexed citations
7.
Bauerfeind, Ingo, Matthias Fischer, S. Kahlert, et al.. (2005). Operation nach prim�r systemischer Therapie des Mammakarzinoms. Der Gynäkologe. 38(3). 193–200. 1 indexed citations
8.
Ditsch, Nina, et al.. (2005). Chemotherapie. Der Onkologe. 11(7). 785–792. 3 indexed citations
9.
Kahlert, S., Franz Koch, Nina Ditsch, & Michael Untch. (2004). Adjuvante Therapie des Mammakarzinoms 2004. Gyn�kologisch-geburtshilfliche Rundschau. 44(2). 102–112. 2 indexed citations
10.
Untch, Michael, S. Kahlert, Luboš Petruželka, et al.. (2004). A multinational phase II study of Navelbine (N) and Herceptin (H) as first-line therapy for patients with HER2-positive metastatic breast cancer (HER2+ MBC). European Journal of Cancer Supplements. 2(3). 127–127. 5 indexed citations
11.
Kahlert, S., Ingo Bauerfeind, Alexander Strauß, & Michael Untch. (2004). Behandlung des Mammakarzinoms in der Schwangerschaft - Erfahrungen aus der Universitätsfrauenklinik Großhadern und Internationale Datenlage. Zentralblatt für Gynäkologie. 126(3). 159–166. 10 indexed citations
12.
Untch, Michael, Franz Koch, S. Kahlert, & Gottfried E. Konecny. (2000). Overview of Epirubicin-Based Adjuvant Therapy in Breast Cancer. Clinical Breast Cancer. 1. S41–S45. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026